ALUR

MKT CAP:$6M

Allurion Technologies Inc.

Market Cap

$6M

Healthcare·Medical - Devices·🇺🇸 United States·NYSE

Healthcare·Medical - Devices·🇺🇸·NYSE

Stock Price

$0.76-$0.69 (-47.72%)

Apr 22, 2026

Company Details

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allur...

CEO

Samuel G. Levy

IPO Date

Mar 29, 2021

Website

www.allurion.com

Key Metrics TTM

Revenue

$17M

-71.2% YoY

Net Income

-$47M

EPS (Diluted)

-$13.67

Free Cash Flow

-$37M

Revenue / Share

$2.28

Gross Margin

49.7%

Operating Margin

-263.4%

Net Margin

-275.6%

FCF Margin

-212.9%

P/S

0.3x

P/E

—

Earnings Reports

Q1 2026

May 13, 2026

PENDING

FY 2025

Mar 30, 2026

$15M-52.6%EPS -$3.81

Q4 2025

Mar 30, 2026

$4M-35.4%EPS -$0.69

Q3 2025

Nov 17, 2025

$3M-50.5%EPS -$1.53

FY 2024

Mar 27, 2025

$32MEPS -$11.64

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 20	$0	$0	-$5.2K
Q1 21	$0	$0	-$392.0K
Q2 21	$0	$0	-$713.0K
Q3 21	$0	$0	-$470.0K
Q4 21	$0	$0	-$657.0K
Q1 22	$13M	$10M	-$6M
Q2 22	$16M	$13M	-$4M
Q3 22	$16M	$13M	-$12M
Q4 22	$19M	$15M	-$10M
Q2 23	$13M	$10M	-$13M
Q3 23	$18M	$14M	-$26M
Q1 24	$9M	$7M	-$11M
Q3 24	$5M	$3M	-$12M
Q4 24	$6M	$3M	-$17M
Q3 25	$3M	$1M	-$10M
Q4 25	$4M	$2M	-$6M

Valuation

Quarter	P/S	P/E
Q4 20	—	—
Q1 21	—	—
Q2 21	—	—
Q3 21	—	7913.0x
Q4 21	—	16.0x
Q1 22	7.3x	20.5x
Q2 22	3.2x	9.4x
Q3 22	5.6x	—
Q4 22	4.1x	—
Q2 23	6.6x	—
Q3 23	3.3x	—
Q1 24	1.2x	—
Q3 24	0.9x	—
Q4 24	0.8x	—
Q3 25	6.2x	—
Q4 25	5.9x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 21	-$2M	-$2M
Q2 21	-$244.2K	-$244.2K
Q4 21	-$121.8K	-$121.8K
Q1 22	-$9M	-$9M
Q2 22	-$12M	-$13M
Q3 22	-$10M	-$10M
Q4 22	-$16M	-$16M
Q2 23	-$20M	-$20M
Q3 23	-$23M	-$24M
Q1 24	-$9M	-$9M
Q3 24	-$11M	-$12M
Q4 24	-$13M	-$13M
Q3 25	-$7M	-$7M
Q4 25	-$5M	-$5M

Capital Expenditures

Quarter	CapEx
Q1 21	$0
Q2 21	$0
Q4 21	$0
Q1 22	$318.0K
Q2 22	$930.0K
Q3 22	$157.0K
Q4 22	$459.0K
Q2 23	$408.0K
Q3 23	$800.0K
Q1 24	$104.0K
Q3 24	$72.0K
Q4 24	$0
Q3 25	$0
Q4 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	—	+12610.4%
Q1 22	—	+4567.6%
Q2 22	—	+2781.2%
Q3 22	—	+5867.9%
Q4 22	—	+4364.5%
Q2 23	+1.9%	+43.5%
Q3 23	+12.0%	+115.9%
Q1 24	-41.6%	-25.9%
Q3 24	-72.0%	-39.6%
Q4 24	-56.9%	-13.5%
Q3 25	-85.4%	-72.3%
Q4 25	-61.5%	-52.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 21	$0	—
Q2 21	$0	—
Q4 21	$0	—
Q1 22	$73.0K	0.6%
Q2 22	$89.0K	0.5%
Q3 22	$93.0K	0.6%
Q4 22	$182.0K	0.9%
Q2 23	$0	0.0%
Q3 23	$6M	30.4%
Q1 24	$552.0K	5.9%
Q3 24	$860.0K	16.0%
Q4 24	$839.0K	15.0%
Q3 25	$0	0.0%
Q4 25	$2M	59.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q4 20	—	—	—	$4.6K
Q1 21	—	—	—	$343.7K
Q2 21	—	—	—	$663.8K
Q3 21	—	—	—	$419.8K
Q4 21	—	—	—	$604.0K
Q1 22	$3M	$4M	$9M	—
Q2 22	$3M	$3M	$11M	—
Q3 22	$5M	$4M	$16M	—
Q4 22	$6M	$5M	$15M	—
Q2 23	$7M	$6M	$10M	—
Q3 23	$7M	$19M	$14M	—
Q1 24	$6M	$6M	$6M	—
Q3 24	$3M	$3M	$5M	—
Q4 24	$4M	$11M	$8M	—
Q3 25	$2M	$6M	$3M	—
Q4 25	$1M	$5M	$2M	—

Revenue by Geography

Quarter	All Other Countries	Chile	France	Spain	Argentina	Australia	Egypt	Italy
Q3 23	$12M	$2M	$4M	$1M	—	—	—	—
Q3 25	$941.0K	$271.0K	—	$282.0K	$272.0K	$24.0K	$450.0K	$418.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$8M	$0	$8M
Q1 23	$10M	$0	$10M
Q2 23	$5M	$0	$5M
Q3 23	$80M	$0	$80M
Q4 23	$38M	$0	$38M
Q1 24	$30M	$0	$30M
Q2 24	$19M	$0	$19M
Q3 24	$29M	$0	$29M
Q4 24	$15M	$0	$15M
Q1 25	$20M	$0	$20M
Q2 25	$13M	$0	$13M
Q3 25	$6M	$0	$6M
Q4 25	$5M	$0	$5M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 20	108M	—	—
Q1 21	108M	+0.0%	—
Q2 21	108M	0.0%	—
Q3 21	108M	0.0%	—
Q4 21	108M	0.0%	+0.0%
Q1 22	54M	-49.5%	-49.5%
Q2 22	54M	0.0%	-49.5%
Q3 22	1M	-98.0%	-99.0%
Q4 22	1M	+0.3%	-99.0%
Q2 23	1M	+0.4%	-98.0%
Q3 23	2M	+48.8%	-97.0%
Q1 24	2M	+22.0%	+82.7%
Q3 24	3M	+30.3%	+137.3%
Q4 24	3M	+1.0%	+138.8%
Q3 25	8M	+199.8%	+381.1%
Q4 25	8M	-2.8%	+283.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 20	—	—
Q1 21	—	—
Q2 21	—	—
Q3 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q2 23	—	—
Q3 23	—	—
Q1 24	$37.2K	252
Q3 24	$21.3K	252
Q4 24	$40.8K	137
Q3 25	$19.4K	137
Q4 25	$88.1K	41

Revenue / Employee